Figure 3

Associations of higher miR-96 and lower PTEN expression levels with a poor prognosis in CCRCC patients. (a) The correlation between miR-96 and PTEN expression in TCGA CCRCC patients (KIRC) was estimated using Pearson’s correlation test. (b–d) Kaplan–Meier curves of overall survival (OS) and progression-free survival (PFS) for miR-96 and PTEN expression in CCRCC patients. miR-96 and PTEN expression was dichotomized into high- and low-expression categories (b, c). CCRCC patients in KIRC were dichotomized based on the expression of miR-96 and PTEN and patients with higher expression levels of both miR-96 and PTEN or lower expression levels of both miR-96 and PTEN were identified for analysis (d).